Mass COVID-19 testing underway at stricken Belgian care homes
Reuters
Published Apr 16, 2020 11:56AM ET
BRUSSELS (Reuters) - Belgium has begun testing more than 210,000 residents and staff at nursing homes, which now account for about half of the coronavirus-related deaths in the country.
Belgium is one of only a few countries in Europe that includes all non-hospitalised people who displayed symptoms of the disease in its daily tally of COVID-19 deaths, even if they had not been confirmed as having had it.
That may help to explain why Belgium, a small country of about 11.5 million people that has been in lockdown since mid-March, now has the fifth highest coronavirus death toll in Europe, more than larger countries such as Germany and the Netherlands.
On Thursday, Belgian medical authorities said the coronavirus death toll had risen to 4,857 people, of which 49% had been in care homes. Of these, only 6.5% were confirmed as having COVID-19. The vast majority were merely suspected cases.
The mass testing at care homes is expected to take around three weeks.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.